Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients
Clinical trial NCT05633420 · COMPLETED
Trial details
- NCT number
- NCT05633420
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-24
- Primary completion
- 2022-09-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.